Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors

2024PharmaceuticalsJournalOpen access

10.3390/ph17050650 Full text16 citations

Authors

23 authors across 8 institutions in 6 countries.

Antonella MessoreFirst author
Paolo Malune
Elisa Patacchini
Valentina Noemi MadiaCorresponding
Davide Ialongo
Merve Arpacioglu
Aurora Albano
Giuseppe Ruggieri
Francesco Saccoliti
Luigi Scipione
Enzo Tramontano
Serena Canton
Angela Corona
Sante Scognamiglio
Annalaura Paulis
Mustapha Suleiman
- Sokoto State University (NG)
Helmi Mohammed Al-Maqtari
Fatma Mohamed A. Abid
- Azzaytuna University (LY)
Sarkar M. A. Kawsar
Murugesan Sankaranarayanan
Roberto Di Santo
Francesca EspositoCorresponding
Roberta CostiSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Computational Drug Discovery Methodslevel 3 · 1.00
Synthesis and biological activitylevel 3 · 1.00
SARS-CoV-2 and COVID-19 Researchlevel 3 · 0.98

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2024 · Pharmaceuticals · 16 citations
https://openalex.org/W4397011406

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors · Sankore